France · Delayed Price · Currency is EUR Amoéba Statistics
Total Valuation
Amoéba has a market cap or net worth of EUR 69.44 million. The enterprise value is 85.46 million.
| Market Cap | 69.44M |
| Enterprise Value | 85.46M |
Important Dates
The next estimated earnings date is Tuesday, December 30, 2025.
| Earnings Date | Dec 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Amoéba has 68.89 million shares outstanding. The number of shares has increased by 9.50% in one year.
| Current Share Class | 68.89M |
| Shares Outstanding | 68.89M |
| Shares Change (YoY) | +9.50% |
| Shares Change (QoQ) | -2.58% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 22.22% |
| Float | 68.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 101.75 |
| PB Ratio | -4.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.61 |
| EV / Sales | 125.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -24.49 |
Financial Position
The company has a current ratio of 0.28
| Current Ratio | 0.28 |
| Quick Ratio | 0.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.81 |
| Interest Coverage | -4.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -60.82% |
| Return on Invested Capital (ROIC) | -161.96% |
| Return on Capital Employed (ROCE) | 243.54% |
| Revenue Per Employee | 34,123 |
| Profits Per Employee | -368,172 |
| Employee Count | 20 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 6.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.09% in the last 52 weeks. The beta is -0.06, so Amoéba's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | +46.09% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 44.78 |
| Average Volume (20 Days) | 501,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amoéba had revenue of EUR 682,459 and -7.36 million in losses. Loss per share was -0.14.
| Revenue | 682,459 |
| Gross Profit | -944,741 |
| Operating Income | -6.06M |
| Pretax Income | -7.36M |
| Net Income | -7.36M |
| EBITDA | -5.74M |
| EBIT | -6.06M |
| Loss Per Share | -0.14 |
Balance Sheet
The company has 741,838 in cash and 16.77 million in debt, giving a net cash position of -16.02 million or -0.23 per share.
| Cash & Cash Equivalents | 741,838 |
| Total Debt | 16.77M |
| Net Cash | -16.02M |
| Net Cash Per Share | -0.23 |
| Equity (Book Value) | -14.27M |
| Book Value Per Share | -0.28 |
| Working Capital | -6.38M |
Cash Flow
In the last 12 months, operating cash flow was -2.65 million and capital expenditures -837,186, giving a free cash flow of -3.49 million.
| Operating Cash Flow | -2.65M |
| Capital Expenditures | -837,186 |
| Free Cash Flow | -3.49M |
| FCF Per Share | -0.05 |
Margins
| Gross Margin | -138.43% |
| Operating Margin | -888.46% |
| Pretax Margin | -1,078.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Amoéba does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.50% |
| Shareholder Yield | -9.50% |
| Earnings Yield | -10.60% |
| FCF Yield | -5.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amoéba has an Altman Z-Score of -3.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.94 |
| Piotroski F-Score | 3 |